Insight into diagnosis of pleural tuberculosis with special focus on nucleic acid amplification tests.


Journal

Expert review of respiratory medicine
ISSN: 1747-6356
Titre abrégé: Expert Rev Respir Med
Pays: England
ID NLM: 101278196

Informations de publication

Date de publication:
08 2022
Historique:
pubmed: 22 6 2022
medline: 30 9 2022
entrez: 21 6 2022
Statut: ppublish

Résumé

Pleural tuberculosis (TB) is the archetype of extrapulmonary TB (EPTB), which mainly affects the pleural space and leads to exudative pleural effusion. Diagnosis of pleural TB is a difficult task predominantly due to atypical clinical presentations and sparse bacillary load in clinical specimens. We reviewed the current literature on the globally existing conventional/latest modalities for diagnosing pleural TB. Bacteriological examination (smear/culture), tuberculin skin testing/interferon-γ release assays, biochemical testing, imaging and histopathological/cytological examination are the main modalities. Moreover, nucleic acid amplification tests (NAATs), Routine tests are not adequate for effective pleural TB diagnosis. The latest molecular/immunological tests as discussed above, and the other tools,

Identifiants

pubmed: 35728039
doi: 10.1080/17476348.2022.2093189
doi:

Substances chimiques

Cell-Free Nucleic Acids 0
Tuberculin 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

887-906

Auteurs

Aishwarya Soni (A)

Centre for Biotechnology, Maharshi Dayanand University, Rohtak, India.
Department of Biotechnology, Deenbandhu Chhotu Ram University of Science and Technology, Sonipat, India.

Astha Guliani (A)

Department of TB & Respiratory Medicine, Pt. BD Postgraduate Institute of Medical Sciences, Rohtak, India.

Kiran Nehra (K)

Department of Biotechnology, Deenbandhu Chhotu Ram University of Science and Technology, Sonipat, India.

Promod K Mehta (PK)

Centre for Biotechnology, Maharshi Dayanand University, Rohtak, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH